Ignite Creation Date:
2024-05-06 @ 1:32 AM
Last Modification Date:
2024-10-26 @ 11:06 AM
Study NCT ID:
NCT01839357
Status:
COMPLETED
Last Update Posted:
2016-07-25
First Post:
2013-04-22
Brief Title:
Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left AtrialLeft Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter
Sponsor:
Bayer
Organization:
Bayer
Organization Data
Organization:
Bayer
Class:
INDUSTRY
Study ID:
16320
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bayer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen Research Development LLC | INDUSTRY |